Priority Technology Holdings Inc (PRTH) - Total Liabilities
Based on the latest financial reports, Priority Technology Holdings Inc (PRTH) has total liabilities worth $2.49 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Priority Technology Holdings Inc net asset momentum to track the company's year-over-year net asset growth rate.
Priority Technology Holdings Inc - Total Liabilities Trend (2015–2025)
This chart illustrates how Priority Technology Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See Priority Technology Holdings Inc (PRTH) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Priority Technology Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Priority Technology Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanwha General
KO:000370
|
Korea | ₩18.07 Trillion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩17.10 Billion |
|
Nextensa NV
BR:NEXTA
|
Belgium | €696.87 Million |
|
Pacific Biosciences of California
NASDAQ:PACB
|
USA | $780.00 Million |
|
Shengjing Bank Co. Ltd
F:6SY
|
Germany | €1.05 Trillion |
|
Zinzino AB Series B
ST:ZZ-B
|
Sweden | Skr1.05 Billion |
|
Anhui Landun Photoelectron Co Ltd
SHE:300862
|
China | CN¥380.07 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Priority Technology Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Priority Technology Holdings Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -24.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Priority Technology Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Priority Technology Holdings Inc (2015–2025)
The table below shows the annual total liabilities of Priority Technology Holdings Inc from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.49 Billion | +25.07% |
| 2024-12-31 | $1.99 Billion | +32.55% |
| 2023-12-31 | $1.50 Billion | +21.14% |
| 2022-12-31 | $1.24 Billion | +2.86% |
| 2021-12-31 | $1.21 Billion | +133.55% |
| 2020-12-31 | $516.39 Million | -11.76% |
| 2019-12-31 | $585.19 Million | +23.64% |
| 2018-12-31 | $473.31 Million | +32532.67% |
| 2017-12-31 | $1.45 Million | +19.66% |
| 2016-12-31 | $1.21 Million | +616.47% |
| 2015-12-31 | $169.18K | -- |
About Priority Technology Holdings Inc
Priority Technology Holdings, Inc. operates as a payment technology company in the United States. The company operates through three segments: Merchant Solutions, Payables, and Treasury Solutions. The company offers merchant solutions, such as full-service acquiring and payment-enabled solutions for B2C transactions, leveraging proprietary software platform, distributed through independent sales … Read more